| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Blueport Acquisition Ltd | CEO and Chairman, Director, 10%+ Owner | Class A Ordinary Share, par value $0.0001 per share | 1,634,750 | 13 Nov 2025 | Indirect | ||
| Q BioMed Inc. | Chief Legal Officer, Director, 10%+ Owner | Common Stock | 926,910 | 26 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BPAC | Blueport Acquisition Ltd | 13 Nov 2025 | 2 | $0 | 4 | CEO and Chairman, Director, 10%+ Owner | 08 Dec 2025, 16:29 |
| BPAC | Blueport Acquisition Ltd | 10 Nov 2025 | 0 | $0 | 3 | CEO and Chairman, Director, 10%+ Owner | 08 Dec 2025, 16:27 |
| /report/000110465922066487-rosenstadt-william-s-2022-05-26 | Q BioMed Inc. | 26 May 2022 | 1 | +$6,250,000,000 | 4 | Chief Legal Officer, Director, 10%+ Owner | 31 May 2022, 15:07 |